XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Compensation - Summary of Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
2022 Equity Inducement Plan    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning Balance 309,000  
Granted 0 0
Number of Shares, Ending Balance 309,000  
Number of Shares, Vested and expected to vest at March 31, 2023 309,000  
Weighted Average Exercise Price Per Share, Beginning Balance $ 21.14  
Granted 0  
Weighted Average Exercise Price Per Share, Ending Balance 21.14  
Weighted Average Exercise Price Per Share, Vested and expected to vest at March 31, 2023 $ 21.14  
Weighted-Average Remaining Contractual Term, Outstanding at March 31, 2023 9 years 7 months 6 days  
Weighted-Average Remaining Contractual Term, Vested and expected to vest at March 31, 2023 9 years 7 months 6 days  
Outstanding at March 31, 2023, Aggregate Intrinsic Value $ 0  
Vested and expected to vest at March 31, 2023, Aggregate Intrinsic Value $ 0  
2021 Equity Incentive Plan    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning Balance 7,634,167  
Granted 1,515,000  
Exercised 75,184  
Forfeiture (90,552)  
Number of Shares, Ending Balance 8,983,431  
Number of Shares, Vested and expected to vest at March 31, 2023 8,983,431  
Exercisable at March 31, 2023 2,828,518  
Weighted Average Exercise Price Per Share, Beginning Balance $ 16.42  
Granted 23.25  
Exercised 15.74  
Forfeiture 20.04  
Weighted Average Exercise Price Per Share, Ending Balance 17.54  
Weighted Average Exercise Price Per Share, Vested and expected to vest at March 31, 2023 17.54  
Exercisable at March 31, 2023 $ 16.55  
Weighted-Average Remaining Contractual Term, Outstanding at March 31, 2023 8 years 8 months 12 days  
Weighted-Average Remaining Contractual Term, Vested and expected to vest at March 31, 2023 8 years 8 months 12 days  
Weighted-Average Remaining Contractual Term, Exercisable at March 31, 2023 8 years 4 months 24 days  
Outstanding at March 31, 2023, Aggregate Intrinsic Value $ 1,099  
Vested and expected to vest at March 31, 2023, Aggregate Intrinsic Value 1,099  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 612  
Exercisable at March 31, 2023, Aggregate Intrinsic Value $ (61)